Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/522"
Predicate | Value (sorted: none) |
---|---|
rdf:type | |
rdf:type | |
rdfs:label | |
?:Evidence_type | |
?:Evidence_enzyme_system | |
?:Evidence_numb_subjects | |
?:Evidence_object_dose | |
?:Evidence_precip_dose | |
?:Evidence_value |
"3.55"
|
dc:creator | |
dc:date |
"11/13/2007 08:06:22"
|
?:content |
"Route of administration: oral
study duration: randomized cross-over design; participants given placebo or 400mg fluconazole on day 1 and 200mg days 2 to 6. A single dose of 7.5mg oral MDZ was given on day 1 and day 6 while .05mg/kg of IV MDZ was given on day 4.
population: 12 healthy volunteers, 7 male, 5 female
ages: 19-25
Day 1 (AUC is 0-infinity) AUC_i/AUC = 3.513
Day 6 (AUC is 0-infinity) AUC_i/AUC = 3.6"
|
rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ fluconazole_increases_auc_midazolam, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1153 }